Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Not Confirmed
Not Confirmed
26-29 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Industry Trade Show
Not Confirmed
26-29 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

04 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sirnaomics-has-been-subscribed-for-17-527-696-subscription-shares-new-capital-injection-to-promote-business-growth-and-development-302267528.html

19 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sirnaomics-announces-demonstration-of-a-novel-mechanism-of-action-of-its-sirna-therapeutics-for-focal-fat-reduction-in-journal-of-cosmetic-dermatology-302252985.html

31 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sirnaomics-announces-a-partnership-with-gore-range-capital-for-establishment-of-a-jv-sagesse-bio-to-advance-its-rnai-therapeutics-into-aesthetic-medicine-302211747.html

11 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sirnaomics-announces-completion-of-ind-enabling-studies-of-safety-and-efficacy-for-stp125g-with-nhp-models-targeting-apoc3-for-treatment-of-cardiovascular-diseases-302195644.html

28 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sirnaomics-announces-completion-of-stp707-phase-i-clinical-study-with-strong-safety-profile-and-disease-activity-for-the-treatment-of-pancreatic-cancer-patients-302185472.html

12 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sirnaomics-demonstrates-strong-antitumor-activity-of-its-novel-oligonucleotide-chemodrug-conjugate-in-journal-of-oncology-research-and-therapy-302171871.html
ABOUT THIS PAGE